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ABSTRACT 
In search of new potential antimicrobial agents, series of trisubstituted 4.5-dihydropyrazoline derivatives have been synthesized starting from 
chalcones. A mixture of 4-phenylbut-3-en-2-one (1, 0.001mmol), phenyl hydrazine hydrochloride (2a-g 0.001mmol) and sodium acetate 
(0.002mmol) in ethyl alcohol was stirred at room temperature for 1 hr to get trisubstituted 4,5-dihydropyrazoles (3a-g) in good yield. Spectral, X-
ray diffraction and elemental analysis confirmed the structures of the products. The synthesised compounds have been evaluated in vitro for their 
antimicrobial activity. The results revealed that some compounds particularly with chloro substituents act as potential antimicrobial agents.  
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INTRODUCTION 
The synthesis ofpyrazoline and its analogues has been a subject of 
consistent interest because of the wide range of applications in the 
pharmaceutical and agrochemical industries.pyrazolines and its 
derivatives, a class of well known nitrogen containing heterocyclic 
compounds occupy an important position in medicinal and pesticide 
chemistry with diverse biological activities such as anti-
inflammatory1, analgesic2, antagonist3, antidepressant and 
anticonvulsant4, hypoglycemic5, antitumour6, antioxidant7, and 
antimicrobial8. The wide range of biological activities ofpyrazolines 
has made them popular synthetic targets. Therefore, extensive 
research efforts are continually directed at the discovery of new 
heterocycles with appropriate pharmacological effects.  
In view of broad spectrum of biological applications; and in 
continuation of our work onpyrazolines, we herein report the 
synthesis, characterization and antimicrobial activity of 4, 5-
dihydropyrazolines derived from 4-phenylbut-3-en-2-one (Scheme-
1).  
MATERIALS AND METHODS 
The chemicals used were purchased from Aldrich chemicals (India). 
Melting points were taken in open capillaries using Thomus Hoover 
melting point apparatus and are uncorrected. The 1H NMR and 13C NMR 
spectra were recorded on a Bruker Supercon 400 MHz 
spectrophotometer in CDCl3; chemical shifts are expressed in δ ppm. The 
coupling constant (J) is expressed in Hz. Mass spectra were obtained on 
Maspec MSW 9629 spectrophotometer. Elemental analysis was obtained 
on a Thermo Finnigan Flash EA 1112 CHN analyser. Chromatographic 
separations were carried out on silica gel (70-230 mesh, Merck) column 
using benzene: ethyl acetate (8:1 v/v) as eluent. 
Synthesis 
In a typical procedure, a mixture of 4-phenylbut-3-en-2-one (1, 
0.001mmol), phenyl hydrazine hydrochloride (2a-g 0.001mmol) and 
sodium acetate in ethyl alcohol was stirred at room temperature for 1 
h. The progress of the reaction was monitored by TLC. After the 
completion of the reaction, the mixture was poured into ice cold water. 
The solid formed was separated and crystallized with acetonitrile to 
get the title compounds (3a-g) in relatively good yield (Scheme-1). 
 
Antimicrobial activity 
Synthesised compounds (3a-g) were evaluated for their 
antimicrobial activity (MIC) 9 against fungal species C. albicans, A. 
niger, A. flavus and bacteria species E. coli, S. typhimurium, B. subtilis. 
The antibiotics amphotericin B and ciprofloxacin were used as 
standard drugs against fungi and bacteria species respectively. 
DMSO is used as control. The experiments were carried out in 
triplicate; the results were taken as a mean of three determinations. 
RESULTS AND DISCUSSION 
1H NMR, 13C NMR, elemental analysis and X-ray diffraction 
crystallographic studies provide the structure proof for the products. 
The structural assignments were made by NMR analysis by 
considering compound (3b) as the representative compound. In its 1H 
NMR spectra, Ha, Hb and Hc protons of the pyrazoline ring appeared 
as a doublet of doublet. The doublets of Ha appeared in the region 
2.61-2.67 ppm; doublets of Hb appeared in the region 3.47-3.53 ppm; 
and that of Hc in the region 5.10-5.14ppm. Doublets of Ha and Hb are 
due to diastereotopic nature of methylene protons. Among Ha, Hb and 
Hc protons, Hc is the most deshielded due to its close proximity to 
benzene ring. Hc couples not only with Ha but also with Hb and 
appears as doublet of doublet instead of a triplet i.e., the methylene 
protons of pyrazoline ring (Ha and Hb) exhibited a typical ABX spin 
system with Hc as a doublet of doublets (Fig-1). Moreover, a collection 
of signal observed in the aromatic region 6.62-7.37 ppm is due to 
aromatic protons, C1 and C5 protons of the pyrazoline ring.  
 
Fig. 1: Proton chemical shifs and couplings of 3b 
Further, the structure of (3b) was confirmed by single crystal XRD 
study10, which was depicted in ORTEP diagram (Fig-2). Analysis of 
torsion angles, asymmetry parameters and least-square plane 
calculation shows that it contains two benzene rings (C1-C6 and C8-
C13), these two rings are attached to the central pyrazoline ring and 
the molecules are connected by non classical hydrogen bonds. The 
dihydropyrazole ring is a shallow envelope, with atom C7 displaced 
from the other four atoms by 0.298 (2) A. The dihedral angles between 
the four near coplanar atoms of the central ring and the N- and C-
bonded phenyl groups are 13.49 (13) and 82.22 (16) ° respectively.  
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Fig. 2: ORTEP diagram of 3b with 50% probability ellipsoids 
The mass spectrum of all the synthesised compounds showed M+1 
molecular ion peak corresponding to its molecular formula which 
confirmed the formation of these compounds. In 13C NMR spectrum 
of compound (3b), a signal at 15.99 ppm is assigned to methyl 
carbon attached to pyrazoline ring at C3. Two signals at 47.74 and 
63.75 ppm are assigned to C4 and C5 respectively. One signal at 
146.04 ppm is attributed to C3 carbon in the pyrazoline ring.  A 
collection of signals appeared in the region 112.97-149.58 ppm 
which are ambiguously assigned to aryl carbons. The physical and 
analytical data; 1H NMR and 13C NMR chemical shifts of synthesised 
compounds (3a-g) are summarized in Table-1, Table-2 and Table-3 
respectively. 
 
Table 1: Physical data of Pyrazolines 3a-g 
Compound Molecular formula Yield (%)  m.p 0C  Mass Elemental analysisa 
 C (%)  H (%)  N (%) 
3a  C10H12N2 58 60-620C 160.10 74.95 7.52 17.45 
3b  C16H16N2 62 90-920C 236.13 81.36 6.80 11.88 
3c  C16H14N4O4 55 220-2220C 326.10 58.90 4.32 17.15 

























aObserved values; which are within ±0.02% from their theoretical values. 
 
Table 2: Proton chemical shift values of pyrazolines 3a-g (δ ppm) 
Compound Ha Hb Hc -CH3/OCH3 NH Aromatic protons 
3a 2.62(dd) 3.47 (dd) 5.11(dd) 1.98 6.9 6.61-7.35 
3b 2.64 (dd) 3.51(dd) 5.13(dd) 2.01 - 6.62-7.37 
3c 2.63 (dd) 3.48 (dd) 5.12(dd) 2.01 - 6.91-8.22 























Table 3: 13C NMR chemical shift values of pyrazolines 3a-g (δ ppm) 
Compound C-3 C-4 C-5 -CH3/OCH3 Aryl carbons 
3a 61.62 39.91 46.82 15.81 126.90-142.54 
3b 63.75 40.02 47.74 15.99 112.97-149.58 
3c 63.81 40.10 48.18 16.20 112.81-150.37 




















The results of minimum inhibitory concentration (MIC) of the 
synthesised compounds (3a-g) against the fungi species C. albicans, 
A. niger and A. flavus are furnished in Table-4. The investigated 
compounds showed different degrees of antifungal activity in 
relation to the tested microbial species. The extent of antifungal 
activity depended on the microorganism and the type of functional 
groups present in the molecule. The activity is considerably affected 
by substituents present at the para position of phenyl ring. A close 
investigation of the in vitro antifungal activity profile of the 
trisubstitutedpyrazolines gives a clear picture of the structure 
activity correlations among the compounds (3a-g) under study. The 
compounds with halogen, methyl or methoxy function present at C-6 
positions of phenyl ring exert varied range of antifungal activity 
while the compounds with no substituents or –NO2 substituent on 
the phenyl groups did not exhibit significant antifungal activity. 
Substitution of halogen at the para position of phenyl groups has 
promoted the activity against C. albicans and A. flavus. However, this 
introduction did not show any improvement against A. niger. 
Similarly, compound which has methoxy group at para position only 
recorded a marked potency. 
 
Table 4: MIC’s of the synthesised compounds (3a-g) against fungi species 
Compound Minimum inhibitory concentration (MIC’s) in µg/mL* 
 C. albicans A. niger A.flavus 
3a 100 100 200 
3b 100 ** 200 
3c 100 ** ** 
3d 100 100 100 
3e 50 50 100 
3f 25 100 50 
3g 50 100 50 
Amphotericin B 25 50 50 
*Results are expressed as mean of three determinations (n=3); **No activity observed even at a concentration of 200 μg/mL. 
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The minimum inhibitory concentration (MIC) results of the 
synthesised compounds (3a-g) against the bacteria species E. 
coli, S. typhimurium, B. subtilis are summarized in Table-5. The 
test compounds exhibited different degrees of antibacterial 
activity in relation to the tested microbial species. The activity is 
considerably affected by substituents present at the para 
position of phenyl ring. The compound (3a) having only one 
aromatic ring substituent showed moderate activity against the 
organisms tested. The compounds (3d) and (3f) with halogen, 
methoxy function present at C-6 positions of phenyl ring exerted 
very good activity; The compounds (3b) and (3g) with no 
substitution and –CH3 substituent on aromatic ring exerted 
moderate activity. however the compound (3c) with –NO2 
substituent on the aromatic ring was found inactive even at a 
higher concentration of 200µg/ml against all the organisms 
tested.  
 
Table 5: MIC’s of the synthesised compounds (3a-g) against bacteria species 
Compound Minimum inhibitory concentration (MIC’s) in µg/mL* 
E. coli S. typhimurium B. subtilis 
3a 100 200 100 
3b 50 50 100 
3c ** ** ** 
3d 25 50 25 
3e 25 50 25 
3f 25 50 25 
3g 50 100 50 
Ciprofloxacin 25 50 25 
*Results are expressed as mean of three determinations (n=3); **No activity observed even at a concentration of 200 μg/mL. 
 
CONCLUSION  
In summary, a series of novel trisubstitutedpyrazolines have been 
synthesized in appreciable yields in an easy accessible method. 
Results of the antimicrobial activity reveal that some of the 
compounds particularly with chloro substituents act as potential 
antimicrobial agents. However, the structure-activity mode of action 
with the host cell remains of interest. 
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